SEC Company Response from Climb Bio, (CLYM) — Jun 5, 2026
Climb Bio, Inc.
Date: June 5, 2026 · CIK: 0001768446 · Accession: 0001193125-26-259490
AI Filing Summary & Sentiment
File numbers found in text: 333-296346
Show Raw Text
CORRESP 1 filename1.htm CORRESP June 5, 2026 VIA EDGAR SUBMISSION U.S. Securities and Exchange Commission Division of Corporation Finance, Office of Life Sciences 100 F Street, NE Washington, DC 20549 Attention: Daniel Crawford Re: Climb Bio, Inc. Registration Statement on Form S-3 Filed May 29, 2026 File No. 333-296346 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Climb Bio, Inc. (the “ Registrant ”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-296346), so that it may become effective at 4:00 p.m., Eastern Time, on June 9, 2026, or as soon as practicable thereafter, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the U.S. Securities and Exchange Commission. Very truly yours, Climb Bio, Inc. By: /s/ Aoife Brennan Name: Aoife Brennan, M.B., Ch.B. Title: President and Chief Executive Officer